Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Evidence- |
RCV000661397 | SCV000783671 | pathogenic | Breast-ovarian cancer, familial, susceptibility to, 2 | 2017-12-15 | reviewed by expert panel | curation | Variant allele predicted to encode a truncated non-functional protein. |
Laboratory of Molecular Diagnosis of Cancer, |
RCV000240691 | SCV000265909 | pathogenic | Breast neoplasm | 2015-11-01 | criteria provided, single submitter | research | |
Labcorp Genetics |
RCV000546284 | SCV000635436 | pathogenic | Hereditary breast ovarian cancer syndrome | 2017-06-04 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Gln1736*) in the BRCA2 gene. It is expected to result in an absent or disrupted protein product. This variant is not present in population databases (ExAC no frequency). This variant has been reported in an individual affected with breast cancer (PMID: 27257965). ClinVar contains an entry for this variant (Variation ID: 224444). Loss-of-function variants in BRCA2 are known to be pathogenic (PMID: 20104584). For these reasons, this variant has been classified as Pathogenic. |
Laboratory of Urology, |
RCV003332142 | SCV004040599 | pathogenic | Malignant tumor of urinary bladder | no assertion criteria provided | research |